Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Tickers GILD NEWS
Tags BZI/POD GILD Market News
From Benzinga
Peering Into Gilead Sciences's Recent Short Interest
Tickers GILD
Tags Short Ideas Benzinga Trading Ideas
From Benzinga
Gilead's Ongoing Battle Against Counterfeit HIV Medications Persists With New Lawsuit, Seizes $750K In Fake Drugs
Tickers GILD NEWS
Tags Market News GILD Large Cap
From Benzinga
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
Tickers GILD NEWS
Tags Health Care Top Stories News
From Benzinga
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
Tickers GILD
Tags GILD Benzinga Market News
From Benzinga
7 Defensive Stocks to Buy as Investors Seek Shelter
Tickers CL CPB ED GILD
Tags MDT GILD Market News
From InvestorPlace
3 Stocks Retirees Should Absolutely Love
Tickers ABBV ABT BMY GILD
Tags BMY Recent Press Releases Market News
From Motley Fool
Analysts Cite Improved Investor Sentiment For Gilead, But Warn of Limited Growth at Current Stock Levels
Tickers GILD NEWS
Tags Top Stories Health Care Earnings
From Benzinga
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Tickers AKAM AXL CARG CSCO
Tags Earnings Tech Bonds
From Benzinga
Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript
Tickers GILD
Tags GILD Market News Recent Press Releases
From Motley Fool
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q2 2024
Tickers GILD
Tags NASDAQ:GILD Market News GILD
From InvestorPlace
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
Tickers AKAM APP ARM BLNK
Tags MUR Commodities Stories That Matter
From Benzinga
Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until...
Tickers AKAM BLNK BMBL CARG
Tags CARG AKAM HBI
From Benzinga
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
Tickers GILD NEWS
Tags Benzinga Trading Ideas News
From Benzinga
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
Tickers ABT GILD
Tags Recent Press Releases Market News GILD
From Motley Fool
Q3’s Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List
Tickers ADP GILD PYPL
Tags PYPL Market News ADP
From InvestorPlace
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Tickers COST GILD MMC ON
Tags GILD Market News insurance stocks
From Benzinga
The Top 3 Biotech Stocks to Buy Now Summer 2024
Tickers AMGN GILD VRTX
Tags Market News GILD NASDAQ:AMGN, NASDAQ:GILD, NASDAQ:VRTX
From InvestorPlace
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
Tickers ABBV AZN BMY GILD
Tags NASDAQ:KZIA,NYSE:ABBV,NYSE:BMY,NYSE:JNJ,NYSE:AZN,NYSE:MRK,NASDAQ:GILD BMY MRK
From InvestorPlace
Gilead Sciences's Options Frenzy: What You Need to Know
Tickers GILD
Tags Markets GILD Market News
From Benzinga
$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
Tickers GILD NEWS
Tags Benzinga Trading Ideas News
From Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Tickers BMY GILD NEWS PFE
Tags Analyst Ratings Wall Street's Most Accurate Analysts BMY
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY CVS GILD JNJ
Tags PFE Benzinga PRCT
From Benzinga
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
Tickers AMD ARM BKNG DXCM
Tags Equities WBD QCOM
From Benzinga
This Is What Whales Are Betting On Gilead Sciences
Tickers GILD
Tags BZI/UOA Benzinga Options
From Benzinga
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
Tickers GILD PAYC PFE
Tags PAYC GILD Market News
From Motley Fool
Gilead's $42.5K Priced HIV Drug Could Be Made At Just $40 Annually, Campaigners Urge Company To Slash Price
Tickers GILD NEWS
Tags Health Care Top Stories Large Cap
From Benzinga
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
Tickers GILD GSK NEWS PFE
Tags PFE Briefs Biotech
From Benzinga
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Tickers ANAB GILD LLY NEWS
Tags General Briefs Expert Ideas
From Benzinga
Breaking Down Gilead Sciences: 10 Analysts Share Their Views
Tickers GILD
Tags BZI/AAR Analyst Ratings GILD
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.